Disc Medicine Quarterly Balance Sheet
NASDAQ: IRONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Disc Medicine financial position
As of Jun 30, 2026, Disc Medicine reported total assets of $735.1 million, up 10.5% from a year earlier against total liabilities of $90.9 million. Shareholders' equity stood at $644.2 million, or 87.6% of assets. The company held $98.7 million in cash and equivalents against $59.3 million of debt, a net cash position of $39.3 million.
The current ratio (current assets divided by current liabilities) was 24.14, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.09.
Summary generated from market data by MetaCap's automated system. Methodology
Disc Medicine balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 98.68M | 88.91M | 91.14M | 140.66M | 127.34M | 122.67M | 192.43M | 192.64M | 280.66M | 342.62M | 360.38M | 370.54M |
| Short-Term Investments | 619.07M | 641.25M | 700.01M | 475.26M | 522.64M | 571.99M | 297.45M | 294.73M | 220.28M | — | 0 | — |
| Total Current Assets | 732.76M | 747.46M | 803.90M | 627.17M | 661.59M | 705.60M | 493.62M | 493.15M | 508.24M | 351.95M | 365.66M | 374.26M |
| Property, Plant & Equipment | 980.00K | 1.07M | 1.16M | 1.23M | 1.29M | 1.37M | 751.00K | 79.00K | 98.00K | 211.00K | 170.00K | 183.00K |
| Total Assets | 735.07M | 750.21M | 806.88M | 630.46M | 665.06M | 709.27M | 496.77M | 495.14M | 510.22M | 354.18M | 368.00M | 376.50M |
| Accounts Payable | 6.84M | 11.76M | 9.02M | 7.27M | 6.35M | 6.70M | 7.95M | 3.55M | 4.75M | 5.27M | 12.63M | 8.50M |
| Total Current Liabilities | 30.36M | 31.14M | 36.64M | 26.74M | 20.61M | 18.74M | 23.32M | 25.47M | 20.31M | 14.85M | 21.44M | 14.42M |
| Long-Term Debt | 59.34M | 29.36M | 29.16M | 28.95M | 28.74M | 28.53M | 28.32M | — | — | — | 0 | — |
| Total Liabilities | 90.91M | 61.78M | 67.05M | 57.06M | 50.90M | 48.90M | 53.19M | 27.18M | 21.39M | 16.11M | 22.88M | 17.52M |
| Shareholders' Equity | 644.16M | 688.43M | 739.83M | 573.39M | 614.16M | 660.36M | 443.59M | 467.96M | 488.83M | 338.07M | 345.12M | 358.97M |
| Retained Earnings | -633.22M | -573.69M | -510.19M | -449.65M | -387.33M | -332.09M | -298.00M | -268.55M | -241.95M | -215.59M | -188.65M | -165.07M |
| Total Debt | 59.34M | 29.36M | 29.16M | 28.95M | 28.74M | 28.53M | 28.32M | — | — | — | 0 | — |
| Net Cash (Debt) | 658.41M | 700.79M | 761.99M | 586.97M | 621.24M | 666.13M | 461.56M | 487.36M | 500.94M | 342.62M | 360.38M | 370.54M |
| Shares Outstanding | 38.35M | 38.19M | 37.89M | 35.01M | 34.69M | 34.58M | 29.87M | 29.75M | 29.71M | 24.70M | 24.36M | 24.14M |
This table shows 12 quarterly periods of Disc Medicine's balance sheet, from Q2 2026 back to Q3 2023, across 15 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow IRON's reporting calendar. What is a balance sheet?